The subscription figures of Rossari Biotech Limited IPO subscription on Day 1 (July 13, 2020) at 05.00 pm.
Overall - 0.60 times
QIB - 0.41 times
HNI - 0.11 times
Retail - 0.92 times
|Issue Size (Fresh+OFS)||Rs 496.24 crore (Fresh Issue Rs.50 crore and OFS Rs.446.25 Crore)|
|Price Band||Rs. 423 - Rs. 425|
|Allocation Category wise||QIB: 50% HNI: 15% and RII 35%|
|Issue Period||July 13, 2020 to July 15, 2020|
|BRLMs||Axis Capital Limited & ICICI Securities Ltd.|
|Advisor||Axcelus Finserv Private Limited|
|Promoters||Mr. Edward Menezes-Executive Chairman and Mr. Sunil Chari - Managing Director of Rossari Biotech Limited|
The Company proposed to raise Rs. 496.24 Cr via the fresh issue of Rs. 50 Cr and OFS of Rs. 446.25 Cr. The net proceeds from the fresh issue to prepay or repay certain indebtedness, including accrued interest, fund working capital requirements and for general corporate purposes.
A total of 8 mutual funds through 20 schemes bid for the anchor portion.
Institutional investors that participated in the anchor allotment included Abu Dhabi Investment Authority, Axis Mutual Fund, Mirae Asset Mutual Fund, Goldman Sachs, HFDC Mutual Fund, SBI Mutual Fund, among others.